CD19-Targeted CAR T Cells: A New Tool in the Fight against B Cell Malignancies

Publisher： Karger

E-ISSN： 2296-5262|38|12|683-690

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.38, Iss.12, 2015-0, pp. : 683-690

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD19 chimeric antigen receptor T cell therapy for haematological malignancies

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 4, 2015-05 ,pp. : 463-478

John Wiley & Sons Inc

Access to resources Recommend Favorite

Amphiregulin promotes the immunosuppressive activity of intrahepatic CD4+ regulatory T cells to impair CD8+ T‐cell immunity against hepatitis B virus infection

By  

IMMUNOLOGY, Vol. 144, Iss. 3, 2015-03 ,pp. : 506-517

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ligation of TLR7 on CD19+CD1dhi B cells suppresses allergic lung inflammation via regulatory T cells

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 6, 2015-06 ,pp. : 1842-1854

John Wiley & Sons Inc

Access to resources Recommend Favorite

B cells expressing CD11b effectively inhibit CD4+ T‐cell responses and ameliorate experimental autoimmune hepatitis in mice

By  

HEPATOLOGY, Vol. 62, Iss. 5, 2015-11 ,pp. : 1563-1575

John Wiley & Sons Inc

Access to resources Recommend Favorite

IL‐17‐producing CD4+ T cells contribute to the loss of B‐cell tolerance in experimental autoimmune myasthenia gravis

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 5, 2015-05 ,pp. : 1339-1347

John Wiley & Sons Inc

Access to resources Recommend Favorite